Roche Holding AG (RHHVF)
Makes medicines and diagnostic tests that detect diseases like cancer and COVID-19.
$450.00+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+42.1%
The outlook
Roche is trading at 450, sitting well above both its 50- and 200-day moving averages and positioned near the upper end of its 52-week range. The single analyst covering the stock rates it a Strong Buy, with an average price target about 3% above the current level. The stock carries a trailing P/E of 24.0, reflecting a premium valuation.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Market cap
$358.54B
52-wk high
$490.33
52-wk low
$300.15
50-day avg
$410.50
200-day avg
$406.49
Trailing P/E
24.0